CIK 0001570562 · Accelerated filer
Evolus, Inc.
Sign in to watch- Ticker
- EOLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461385614
- Phone
- (949) 284-4555
- Business address
- 520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
- Former names
- Evolus, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $950,019
- in 1 filing
Net −$950,019. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 29 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-13 | GILL DAVID N Director | Sale | −3,643 | $12.72 | $46K | 40,682 |
| 2024-05-13 | Malik Vikram Director | Sale | −28,000 | $12.93 | $362K | 254,014 |
| 2024-05-10 | MOATAZEDI DAVID See Remarks | Sale | −16,051 | $12.72 | $204K | 673,563 |
| 2024-05-10 | Avelar Rui See Remarks | Sale | −3,441 | $12.72 | $44K | 368,847 |
| 2024-05-10 | Beaver Sandra Chief Financial Officer | Sale | −2,423 | $12.72 | $31K | 151,778 |
| 2024-03-27 | MOATAZEDI DAVID See Remarks | Sale | −6,236 | $13.86 | $86K | 689,614 |
| 2024-03-19 | Avelar Rui See Remarks | Sale | −27,603 | $13.92 | $384K | 372,288 |
| 2024-03-19 | Beaver Sandra Chief Financial Officer | Sale | −5,672 | $13.92 | $79K | 154,201 |
| 2024-03-19 | MOATAZEDI DAVID See Remarks | Sale | −96,566 | $13.92 | $1.3M | 695,850 |
| 2024-02-22 | MOATAZEDI DAVID See Remarks | Sale 10b5-1 | −7,706 | $13.08 | $101K | 792,416 |
| 2024-02-22 | Avelar Rui See Remarks | Sale 10b5-1 | −1,821 | $13.08 | $24K | 399,891 |
| 2024-02-22 | Beaver Sandra Chief Financial Officer | Sale 10b5-1 | −1,821 | $13.08 | $24K | 159,873 |
| 2024-02-21 | MOATAZEDI DAVID See Remarks | Grant or award 10b5-1 | +61,202 | 800,122 | ||
| 2024-02-21 | Avelar Rui See Remarks | Grant or award 10b5-1 | +13,115 | 401,712 | ||
| 2024-02-21 | Beaver Sandra Chief Financial Officer | Grant or award 10b5-1 | +13,115 | 161,694 | ||
| 2024-02-07 | BLANK SIMONE Director | Grant or award | +6,464 | 69,747 | ||
| 2024-02-07 | BLANK SIMONE Director | Grant or award · Stock Option (Right to Buy) | +9,377 | 9,377 | ||
| 2024-02-07 | GILL DAVID N Director | Grant or award | +6,464 | 44,325 | ||
| 2024-02-07 | GILL DAVID N Director | Grant or award · Stock Option (Right to Buy) | +9,377 | 9,377 | ||
| 2024-02-07 | Stewart Brady Director | Grant or award | +6,464 | 51,265 |
Page 5 of 16 · 303 trades